MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2021

    Hearing Impairment was not associated with Dream Enactment Behavior and Parkinsonism in the Population: a CLSA Prospective Study

    C. Yao, A. Szpindel, A. Pelletier, R. Postuma (Montréal, Canada)

    Objective: To assess the associations of hearing function with the progression of parkinsonism in a population-based prospective study. Background: Hearing impairment is a common symptom…
  • MDS Virtual Congress 2021

    Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson’s Disease

    G. Deuschl, R. Jain, J. Wang, M. Barbe, S. Paschen, C. Sik Lee, J. Volkmann, A. Kühn, J. Vesper (Kiel, Germany)

    Objective: To report real-world, long-term outcomes using a Directional DBS System with multiple independent current source control (MICC) for use in managing symptoms of levodopa-responsive…
  • MDS Virtual Congress 2021

    An Eye of a Tiger cannot see all the true: a case series.

    I. Teixeira, S. Trivellato, I. Fonseca, D. Margato, R. Bazan, A. Schelp (Botucatu, Brazil)

    Objective: Describe patients with Multiple System Atrophy with iron accumulation in neuroimaging of striatal regions. Background: MSA is an adult neurodegenerative disease with parkinsonism, cerebelar…
  • MDS Virtual Congress 2021

    Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Characterization of Acute Nausea During Dose Titration

    W. Ondo, R. Hauser, A. Bowling, S. Isaacson, E. Pappert, B. Navia (Houston, USA)

    Objective: Characterize acute episodes of nausea experienced by patients with Parkinson’s disease (PD) receiving apomorphine sublingual film (APL) for the on-demand treatment of “OFF” episodes.…
  • MDS Virtual Congress 2021

    LY-487,379 enhances the anti-parkinsonian action of a low dose of L-DOPA in the MPTP-lesioned marmoset

    C. Kwan, I. Frouni, S. Nuara, S. Belliveau, A. Hamadjida, W. Kang, D. Bédard, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To investigate the effect of selective metabotropic glutamate type 2 (mGlu2) receptor positive allosteric modulation on the anti-parkinsonian action of a low dose of…
  • MDS Virtual Congress 2021

    TELEMONITORING OF THE ORAL HEALTH OF PARKINSONIANS DURING THE NEW CORONAVIRUS PANDEMIC

    C. da Silva, J. de Oliveira, N. Filho, T. da Silva, V. Marques, G. Monteiro, R. Tavares, M. Borges Andrade, A. Sobral, C. Accioly Lins (Recife, Brazil)

    Objective: To Promote telemonitoring of the oral health of people with Parkinson disease in times of Covid-19. Background: Among the most affected population by Covid-19…
  • MDS Virtual Congress 2021

    Alterations in brain functional network connectivity in Parkinson’s disease patients with MCI

    K. Sreenivasan, X. Zhuang, J. Caldwell, A. Ritter, D. Cordes, Z. Mari, V. Mishra (Las Vegas, USA)

    Objective: To investigate functional network abnormalities in Parkinson’s disease patients with mild cognitive impairment (PD-MCI) and PD patients who are cognitively normal (PD-NC). Background: Cognitive…
  • MDS Virtual Congress 2021

    The association of β-amyloid with cognition and striatal dopamine in early, non-demented Parkinson’s disease

    YS. Oh, SW. Yoo, CH. Lyoo, KS. Lee, JS. Kim (Seoul, Republic of Korea)

    Objective: The purpose of this study was to investigate the association among striatal dopaminergic availability, Aβ-positivity, and motor and cognitive status in early and non-demented…
  • MDS Virtual Congress 2021

    Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

    H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

    Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…
  • MDS Virtual Congress 2021

    Long-Term Motor Function and Quality of Life Outcomes from a Prospective, International DBS Registry

    G. Deuschl, R. Jain, J. Wang, M. Barbe, S. Paschen, C. Sik Lee, J. Volkmann, A. Kühn, J. Vesper (Kiel, Germany)

    Objective: To report the outcomes of an ongoing prospective, international, large-scale registry of Deep Brain Stimulation (DBS) systems for Parkinson’s Disease. Background: Several studies have…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley